Cagrilintide is a synthetic peptide analogue of amylin, engineered for extended activity through structural modifications that enhance half-life and receptor interaction. As a research compound, it has shown strong potential in studies exploring satiety signaling, delayed gastric emptying, and appetite regulation — particularly in the context of metabolic disorders and weight-related pathways.
This compound is offered as a lyophilized powder in sterile, unlabeled glass vials to ensure purity and versatility in research settings. Our 10-vial research kits are produced under stringent quality control protocols and are independently batch-tested for identity and purity.
Each vial is intended for in vitro use only. Not for human consumption. Not for therapeutic or diagnostic purposes.
